Mo et al. demonstrated that TNF-α was up-regulated in OVA-induced allergic rhinitis mouse model and treatment with TNF-α inhibitor (infliximab) induced anti-allergic effects by decreasing local and systemic Th2 responses [47]. Here, TNF is linked to allergic rhinitis.